PL2056675T3 - Metody leczenia zapalenia błony śluzowej jamy ustnej - Google Patents

Metody leczenia zapalenia błony śluzowej jamy ustnej

Info

Publication number
PL2056675T3
PL2056675T3 PL07839531T PL07839531T PL2056675T3 PL 2056675 T3 PL2056675 T3 PL 2056675T3 PL 07839531 T PL07839531 T PL 07839531T PL 07839531 T PL07839531 T PL 07839531T PL 2056675 T3 PL2056675 T3 PL 2056675T3
Authority
PL
Poland
Prior art keywords
methods
oral mucositis
treating oral
treating
mucositis
Prior art date
Application number
PL07839531T
Other languages
English (en)
Inventor
David M. Rothstein
Chris Murphy
Vivian Wong
Glen Kazo
Original Assignee
Galera Labs, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galera Labs, Llc filed Critical Galera Labs, Llc
Publication of PL2056675T3 publication Critical patent/PL2056675T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL07839531T 2006-10-12 2007-10-12 Metody leczenia zapalenia błony śluzowej jamy ustnej PL2056675T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82929106P 2006-10-12 2006-10-12
PCT/US2007/021897 WO2008045559A2 (en) 2006-10-12 2007-10-12 Methods of treating oral mucositis
EP07839531.6A EP2056675B1 (en) 2006-10-12 2007-10-12 Methods of treating oral mucositis
US11/871,848 US9855279B2 (en) 2006-10-12 2007-10-12 Methods of treating oral mucositis

Publications (1)

Publication Number Publication Date
PL2056675T3 true PL2056675T3 (pl) 2019-08-30

Family

ID=39283481

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07839531T PL2056675T3 (pl) 2006-10-12 2007-10-12 Metody leczenia zapalenia błony śluzowej jamy ustnej

Country Status (13)

Country Link
US (5) US9855279B2 (pl)
EP (2) EP3527079A1 (pl)
AU (1) AU2007308141B2 (pl)
CA (1) CA2665984C (pl)
CY (1) CY1121530T1 (pl)
DK (1) DK2056675T3 (pl)
ES (1) ES2725023T3 (pl)
HU (1) HUE044234T2 (pl)
LT (1) LT2056675T (pl)
PL (1) PL2056675T3 (pl)
PT (1) PT2056675T (pl)
SI (1) SI2056675T1 (pl)
WO (1) WO2008045559A2 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008045559A2 (en) 2006-10-12 2008-04-17 Activbiotics Methods of treating oral mucositis
EP2296645B1 (en) * 2008-05-22 2014-11-19 Galera Therapeutics, LLC Combination antitumor therapy
ES2857252T3 (es) 2011-04-29 2021-09-28 Moberg Pharma Ab Composiciones farmacéuticas que comprenden un anestésico local tal como bupivacaína para administración local en la boca o la garganta
HK1199261A1 (en) 2011-09-26 2015-06-26 Galera Labs, Llc Methods for treatment of diseases
DE102012013482A1 (de) * 2012-07-09 2014-01-09 Bitop Ag Zusammensetzung zur Förderung der Wiederherstellung von verletztem Körpergewebe
WO2017027728A1 (en) 2015-08-11 2017-02-16 Galera Labs, Llc Pentaaza macrocyclic ring complexes possessing oral bioavailability
US12220420B2 (en) 2016-05-03 2025-02-11 Galera Labs, Llc Combination therapy for cancer treatment
AU2017318718B2 (en) 2016-09-01 2023-06-29 Galera Labs, Llc Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
EP3582753A4 (en) * 2017-02-15 2020-12-16 Galera Labs, LLC MACROCYCLIC PENTAAZA RING COMPLEXES FOR LOCAL INTESTINAL ADMINISTRATION
EA201992431A1 (ru) 2017-10-13 2020-03-13 ГАЛЕРА ЛЭБЗ, ЭлЭлСи Комбинированная иммунотерапия рака с использованием пента-аза-макроциклического кольцевого комплекса
MX2020008028A (es) * 2018-01-31 2020-12-11 Galera Labs Llc Terapia de combinacion para cancer con complejo de anillo macrociclico de pentaaza y agente anticancer basado en platino.
CN112839663A (zh) 2018-08-14 2021-05-25 托斯克公司 降低氟尿嘧啶诱发的毒性的方法和组合物
US11446303B2 (en) 2019-06-21 2022-09-20 Tosk, Inc. Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions
CN114401736A (zh) * 2019-08-13 2022-04-26 佩蒂诺沃生物制药公司 用于治疗伴随癌症治疗发生的化学疗法诱导的周围神经病变的palm
IL299703A (en) 2020-07-07 2023-03-01 Tosk Inc Uridine phosphorylase inhibitors for the treatment or prevention of lung disease
WO2023009500A1 (en) * 2021-07-27 2023-02-02 Galera Labs, Llc Pentaaza macrocyclic ring complex for enhanced surgical treatment
CN119855603A (zh) * 2022-05-16 2025-04-18 杰诺福克斯有限公司 超氧化物歧化酶及其在预防或治疗粘膜炎中的用途
WO2024026273A1 (en) * 2022-07-25 2024-02-01 Galera Labs, Llc Therapy for reduced ototoxicity from chemotherapeutic agent with pentaaza macrocyclic ring complex

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001212A (en) 1973-10-03 1977-01-04 E. I. Du Pont De Nemours And Company Macrocyclic polyamines
US3930867A (en) 1974-01-07 1976-01-06 E. I. Du Pont De Nemours And Company Macrocyclic polyamines as sensitizers for silver halide emulsions
JPS61226751A (ja) 1985-03-30 1986-10-08 Konishiroku Photo Ind Co Ltd ハロゲン化銀写真感光材料用処理液及びその処理方法
US5096724A (en) 1988-06-03 1992-03-17 Aquanautics Corporation Methods, compositions, and systems for ligand extraction
GB9001245D0 (en) 1990-01-19 1990-03-21 Salutar Inc Compounds
CA2072934C (en) 1991-07-19 2007-08-28 Karl William Aston Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
WO1993002090A1 (en) 1991-07-19 1993-02-04 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
US6204259B1 (en) 1993-01-14 2001-03-20 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
JPH10500401A (ja) 1994-04-22 1998-01-13 モンサント カンパニー 金属錯体を用いる診断画像解析法
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
JPH0840941A (ja) 1994-07-29 1996-02-13 Kanegafuchi Chem Ind Co Ltd 炎症性腸疾患治療製剤
US6525041B1 (en) 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
EP0846003A1 (en) 1995-08-17 1998-06-10 Monsanto Company Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
EP0844889A1 (en) 1995-08-17 1998-06-03 Monsanto Company Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
US20050171198A1 (en) * 1997-06-20 2005-08-04 Metaphore Pharmaceuticals, Inc. SODm therapy for treatment, prevention, inhibition and reversal of inflammatory disease
US20020128248A1 (en) 1997-06-20 2002-09-12 Metaphore Pharmaceuticals, Inc SODm therapy for prevention and/or treatment of inflammatory disease
US20060270639A1 (en) 1997-06-20 2006-11-30 Daniela Salvemini Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs
US6214817B1 (en) 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
US6180620B1 (en) 1997-06-20 2001-01-30 G.D. Searle & Co. Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
JP2991172B2 (ja) 1997-10-24 1999-12-20 日本電気株式会社 半導体装置
AU737650B2 (en) 1997-11-03 2001-08-23 Duke University Substituted porphyrins
GB9817845D0 (en) 1998-08-17 1998-10-14 Glaxo Group Ltd Chemical compounds
US6040330A (en) 1999-01-08 2000-03-21 Bionumerik Pharmaceuticals, Inc. Pharmaceutical formulations of taxanes
DE60037768T2 (de) 1999-05-27 2009-01-15 Pharmacia Corp.(N.D.Ges.D.Staates Delaware) Biomaterialien, modifiziert mit Superoxid-Dismutase Imitatoren
US6448239B1 (en) 1999-06-03 2002-09-10 Trustees Of Princeton University Peroxynitrite decomposition catalysts and methods of use thereof
EP1263447B1 (en) 2000-02-08 2013-06-26 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US7279160B2 (en) 2000-05-02 2007-10-09 The Uab Research Foundation Combinations of DR5 antibodies and other therapeutic agents
EP1315481B1 (de) 2000-08-29 2006-12-06 Mepha AG Arzneimittel zur behandlung von darmerkrankungen
US7166910B2 (en) 2000-11-28 2007-01-23 Knowles Electronics Llc Miniature silicon condenser microphone
US20020072512A1 (en) 2000-12-08 2002-06-13 Metaphore Pharmaceuticals, Inc Method of preventing and treating HIV-mediated central nervous system damage
EP1347773B1 (en) 2001-01-05 2010-04-14 Metaphore Pharmaceuticals Inc. Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
US20030050297A1 (en) * 2001-01-19 2003-03-13 Crapo James D. Cancer therapy
EP1353655A2 (en) 2001-01-26 2003-10-22 Metaphore Pharmaceuticals Inc. Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
RU2003129271A (ru) 2001-03-02 2005-03-20 Метафор Фармасьютикалз, Инк. (Us) Хроматография комплексов металлов
US20040137638A1 (en) 2002-03-04 2004-07-15 Slomczynska Urszula J. Chromatography of metal complexes
WO2002100395A1 (en) * 2001-06-08 2002-12-19 Genzyme Corporation Bismuth salts of anti-oxidants and radical scavengers for prevention and treatment of mucous membrane ulcers
US20040132706A1 (en) 2001-10-05 2004-07-08 Daniela Salvemini Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
KR20040081422A (ko) 2001-11-01 2004-09-21 유에이비 리서치 파운데이션 종양 괴사 인자-관련 세포사멸-유도 리간드 수용체에선택적인 항체와 다른 치료제와의 복합물
AU2003229923A1 (en) * 2002-04-16 2003-11-03 Isis Innovation Limited Curcumin for the prevention and/or treatment of tissue damage
US20050101581A1 (en) 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2
US6781231B2 (en) 2002-09-10 2004-08-24 Knowles Electronics Llc Microelectromechanical system package with environmental and interference shield
US6798047B1 (en) 2002-12-26 2004-09-28 Amkor Technology, Inc. Pre-molded leadframe
WO2005042718A2 (en) * 2003-10-31 2005-05-12 Metaphore Pharmaceuticals, Inc. Compositions and methods for treating, preventing, reversing and inhibiting pain
US7510710B2 (en) 2004-01-08 2009-03-31 The Regents Of The University Of Colorado Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
AU2005231336A1 (en) 2004-03-29 2005-10-20 Inotek Pharmaceuticals Corporation Pyridyl-Substituted Porphyrin Compounds and methods of use thereof
US7262498B2 (en) 2004-10-19 2007-08-28 Hewlett-Packard Development Company, L.P. Assembly with a ring and bonding pads formed of a same material on a substrate
US20070148154A1 (en) 2004-12-17 2007-06-28 Universite Rene Descartes (Paris V) Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs
US8217166B2 (en) 2005-05-05 2012-07-10 Galera Therapeutics, Llc Polyethylene glycolated superoxide dismutase mimetics
WO2006083508A2 (en) 2005-01-10 2006-08-10 Metaphore Pharmaceuticals Inc. Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs
WO2006078713A2 (en) 2005-01-19 2006-07-27 Metaphore Pharmaceuticals, Inc. Methotrexate combinations for treating inflammatory diseases
JP2008534604A (ja) 2005-03-31 2008-08-28 シェーリング コーポレイション スピロ環式トロンビンレセプターアンタゴニスト
CN2870352Y (zh) 2005-12-23 2007-02-14 瑞声声学科技(深圳)有限公司 微机电系统传声器扣合式封装结构
EP2020998A4 (en) 2006-05-23 2010-07-21 Univ Utah Res Found Compositions and methods for the inhibition of endothelial nitric oxide synthase activity
WO2008027547A2 (en) 2006-08-31 2008-03-06 The Brigham And Women's Hospital, Inc. Antioxidant therapies
US20080161324A1 (en) 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
WO2008045559A2 (en) 2006-10-12 2008-04-17 Activbiotics Methods of treating oral mucositis
TWI333264B (en) 2007-01-10 2010-11-11 Advanced Semiconductor Eng Packaging structure and method of mems microphone
EP2259776A4 (en) 2008-02-29 2011-03-16 Eagle Pharmaceuticals Inc USEFUL TOPOTECAN SOLUTIONS
MX2010011307A (es) 2008-04-15 2010-11-09 Intermune Inc Nuevos inhibidores de la replicacion del virus de hepatitis c.
EP2296645B1 (en) 2008-05-22 2014-11-19 Galera Therapeutics, LLC Combination antitumor therapy
US8642557B2 (en) 2010-03-12 2014-02-04 Abbvie Biotherapeutics Inc. CTLA4 proteins and their uses
HK1199261A1 (en) 2011-09-26 2015-06-26 Galera Labs, Llc Methods for treatment of diseases
US9238659B2 (en) 2012-11-19 2016-01-19 The University Of Hong Kong Method of using binuclear gold (I) compounds for cancer treatment
WO2017027728A1 (en) 2015-08-11 2017-02-16 Galera Labs, Llc Pentaaza macrocyclic ring complexes possessing oral bioavailability
US12220420B2 (en) 2016-05-03 2025-02-11 Galera Labs, Llc Combination therapy for cancer treatment
AU2017318718B2 (en) 2016-09-01 2023-06-29 Galera Labs, Llc Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
EP3582753A4 (en) 2017-02-15 2020-12-16 Galera Labs, LLC MACROCYCLIC PENTAAZA RING COMPLEXES FOR LOCAL INTESTINAL ADMINISTRATION
EP3388082A1 (en) 2017-04-13 2018-10-17 Galera Labs, LLC Combination cancer immunotherapy with pentaaza macrocyclic ring complex
MX2019012259A (es) 2017-04-13 2020-02-26 Galera Labs Llc Inmunoterapia combinada contra el cancer con complejo de anillo pentaazamacrociclico.
EA201992431A1 (ru) 2017-10-13 2020-03-13 ГАЛЕРА ЛЭБЗ, ЭлЭлСи Комбинированная иммунотерапия рака с использованием пента-аза-макроциклического кольцевого комплекса
MX2020008028A (es) 2018-01-31 2020-12-11 Galera Labs Llc Terapia de combinacion para cancer con complejo de anillo macrociclico de pentaaza y agente anticancer basado en platino.

Also Published As

Publication number Publication date
EP3527079A1 (en) 2019-08-21
US11612608B2 (en) 2023-03-28
WO2008045559A2 (en) 2008-04-17
EP2056675A4 (en) 2011-01-19
HUE044234T2 (hu) 2019-10-28
AU2007308141A1 (en) 2008-04-17
CA2665984A1 (en) 2008-04-17
CA2665984C (en) 2017-02-28
US20200215077A1 (en) 2020-07-09
US9855279B2 (en) 2018-01-02
CY1121530T1 (el) 2020-05-29
AU2007308141B2 (en) 2013-08-29
US20180333421A1 (en) 2018-11-22
WO2008045559A3 (en) 2008-07-31
SI2056675T1 (sl) 2019-08-30
US9642861B2 (en) 2017-05-09
US20140343028A1 (en) 2014-11-20
ES2725023T3 (es) 2019-09-18
US20230218633A1 (en) 2023-07-13
US20080269185A1 (en) 2008-10-30
DK2056675T3 (en) 2019-04-23
PT2056675T (pt) 2019-05-09
LT2056675T (lt) 2019-05-27
EP2056675A2 (en) 2009-05-13
US10610533B2 (en) 2020-04-07
EP2056675B1 (en) 2019-01-09

Similar Documents

Publication Publication Date Title
SI2056675T1 (sl) Postopki za zdravljenje oralnega mukozitisa
EP2032131A4 (en) Methods of Treatment
ZA200900388B (en) Compositions and methods for the treatment of mucositis
IL248204A0 (en) Combined treatment of tumors expressing 38cd
IL198663A0 (en) Tissue treatment methods
IL193460A0 (en) Compounds and methods for treatment of stroke
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
EP2049139A4 (en) TREATMENT OF TUMORS EXPRESSING RAS
ZA200900140B (en) Methods and compositions for treating biofilms
GB0705854D0 (en) Methods of construction
GB0605360D0 (en) Method of manufacture
GB0600692D0 (en) Well treatment
GB0610746D0 (en) Method of treatment
IL196638A0 (en) Methods and compositions for treating disease
GB0608190D0 (en) Method of purification
ZA200900638B (en) Method of diagnosis
EP2164494A4 (en) Methods of Treatment
ZA200900639B (en) Method of diagnosis
GB0723100D0 (en) Treatment of HFnEF
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
IL194798A0 (en) Treatment of melanoma
ZA200901009B (en) Aza-benzothiophenyl compounds and methods of use
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
GB0604460D0 (en) Treatment